Medical Data Vision (EBM Provider®) Health Insurance Association Database (Japan)
Medical Data Vision Co., Ltd.
Sumitomo Fudosan Kanda Bldg.
7 Kandamitoshirocho
Chiyoda-ku
Tokyo 101-0053
JAPAN
Phone: +81 3 5283 6911
Fax: +81 3 5283 6811
Email: ebm_sales@mdv.co.jp (English acceptable)
Please complete the contact form:https://en.mdv.co.jp/application/contactus/form.php
N/A
Jun 16, 2021: New database profile from the Netherlands
Managed by the Netherlands Comprehensive Cancer Organisation (IKNL), the Netherlands Cancer Registry is the only oncological hospital registry in the Netherlands with data on all cancer patients. Data are available on national level from 1989 onwards. The Netherlands has about 17,000,000 inhabitants. Annually, there are 116,500 new diagnoses of cancer and 44,000 cancer deaths in the Netherlands.
Netherlands Cancer Registry (Netherlands)
Jolanda Sinha
Press Officer
Postbus 19079, 3501 DB
Utrecht
THE NETHERLANDS
Email: j.sinha@iknl.nl
Phone: + 31 88 234 60 00
Mobile: +31 6 34 62 02 29
Dr. Otto Visser
Head of Cancer Registration
Postbus 19079, 3501 DB
Utrecht
THE NETHERLANDS
Email: o.visser@iknl.nl
Phone: + 31 88 234 60 00
Mobile: +31 6 18 41 86 67
1. Augustinus S, Schafrat PJM, Janssen BV, Bonsing BA, Brosens LAA, Busch OR, Crobach S, Doukas M, van Eijck CH, van der Geest LGM, Groot Koerkamp B, de Hingh IHJT, Raicu GM, van Santvoort HC, van Velthuysen ML, Verheij J, Besselink MG, Farina Sarasqueta A; Dutch Pancreatic Cancer Group. Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer. Ann Surg Oncol. 2023 Aug;30(8):5051-5060.
2. Mols F, Schoormans D, Netea-Maier R, Husson O, Beijer S, Van Deun K, Zandee W, Kars M, Wouters van Poppel PCM, Simsek S, van Battum P, Kisters JMH, de Boer JP, Massolt E, van Leeuwaarde R, Oranje W, Roerink S, Vermeulen M, van de Poll-Franse L. Determinants and mediating mechanisms of quality of life and disease-specific symptoms among thyroid cancer patients: the design of the WaTCh study. Thyroid Res. 2023 Jul 10;16(1):23.
3. Oymans EJ, de Kroon CD, Bart J, Nijman HW, van der Aa MA. Incidence of gynaecological cancer during the COVID-19 pandemic: A population-based study in the Netherlands. Cancer Epidemiol. 2023 Jun 20;85:102405. doi: 10.1016/j.canep.2023.102405. Epub ahead of print.
4. Siebinga TM, Janssen SHM, Boumans AW, van Eenbergen MC, Siflinger B, van der Graaf WTA, Husson O. Financial outcomes of Adolescent and Young Adult cancer survivors: a longitudinal population-based registry study. J Natl Cancer Inst. 2023 Jun 6:djad107. doi: 10.1093/jnci/djad107. Epub ahead of print.
5. Rijken A, Loef C, van de Wouw YAJ, van Erning FN, de Hingh IHJT. Updated Incidence, Treatment and Survival of a Nationwide Cohort of Patients with Peritoneal Metastases of Unknown Origin. Indian J Surg Oncol. 2023 Jun;14(Suppl 1):67-73.
6. Rijken A, Galanos LJK, Burger JWA, Nienhuijs SW, van Erning FN, de Hingh IHJT. Peritoneal Metastases from Extraperitoneal Primary Tumors: Incidence, Treatment, and Survival from a Nationwide Database. Indian J Surg Oncol. 2023 Jun;14(Suppl 1):60-66.
7. Maas CCHM, van Klaveren D, Visser O, Merkx MAW, Lingsma HF, Lemmens VEPP, Dinmohamed AG. Number of life-years lost at the time of diagnosis and several years post-diagnosis in patients with solid malignancies: a population-based study in the Netherlands, 1989-2019. EClinicalMedicine. 2023 May 11;60:101994.
8. Padilla CS, Ho VKY, Mooijenkind TWAN, Louwman MWJ, de Vos FYFL, Bekkenk MW, Minnaard WA, Loef C, van Zanten SEMV. Brain metastases in adult patients with melanoma of unknown primary in the Netherlands (2011-2020). J Neurooncol. 2023 May;163(1):239-248.
9. Nuijens ST, van Hoogstraten LMC, Meijer RP, Kiemeney LA, Aben KKH, Witjes JA. Minimum Volume Standards: An Incentive To Perform More Radical Cystectomies? Eur Urol Open Sci. 2023 Mar 31;51:47-54.
10. Yildirim H, Schuurman MS, Widdershoven CV, Lagerveld BW, van den Brink L, Ruiter AEC, Beerlage HP, van Moorselaar RJA, Graafland NM, Bex A, Aben KKH, Zondervan PJ. Variation in the management of cT1 renal cancer by surgical hospital volume: A nationwide study. BJUI Compass. 2023 Mar 4;4(4):455-463.
Jun 4, 2021: We now bring you the HES profile from UK
Containing over 80M patients, the Hospital Episode Statistics (HES) Database (United Kingdom) consists of all secondary care activity in England starting April 2009. Data are collected by all NHS Trusts in England and reported on a monthly basis. Patient characteristics are also included in the database, such as age, gender and ethnicity.
Hospital Episode Statistics (HES) Database (United Kingdom)
Hannah Matthews
Email: hannahmatthews@openhealthgroup.com
1. Email: support@harveywalsh.co.uk
2. You may also try completing the contact form at: https://www.openhealthgroup.com/contact-us
1. Beecroft S, O’Connell M, Nassar A, Noon K, Pollock KG, Palmer D, Cross TJ. Major variation in hepatocellular carcinoma treatment and outcomes in England: a retrospective cohort study. Frontline Gastroenterology. 2023 Jan 1;14(1):19-24.
2. Cox T, O’Connell M, Leeuwenkamp O, Palimaka S, Reed N. Real-world comparison of healthcare resource utilization and costs of [177Lu] Lu-DOTA-TATE in patients with progressive neuroendocrine tumors in England: a matched cohort analysis using data from the hospital episode statistics dataset. Current Medical Research and Opinion. 2022 Aug 3;38(8):1305-17.
3. Yakutcan U, Demir E, Hurst JR, Taylor PC, Ridsdale HA. Operational modeling with health economics to support decision making for copd patients. Health Services Research. 2021 Dec;56(6):1271-80.
4. Shah A, Hawley S, Inman DS, Cooper C, Fagan E, Johansen A, Judge A. Geographical variation in surgical care and mortality following hip fracture in England: a cohort study using the National Hip Fracture Database (NHFD). Osteoporosis International. 2021 Oct 1:1-0.
5. Parry-Smith W, Okoth K, Subramanian A, Gokhale KM, Chandan JS, Humpston C, Coomarasamy A, Nirantharakumar K, Šumilo D. Postpartum haemorrhage and risk of mental ill health: A population-based longitudinal study using linked primary and secondary care databases. J Psychiatr Res. 2021 May;137:419-425.
6. Keltie K, Cognigni P, Gross S, Urwin S, Burn J, Cole H, Berry L, Patrick H, Sims A. Comparison of identifiable and non-identifiable data linkage: health technology assessment of MitraClip using registry, administrative and mortality datasets. BMJ Health Care Inform. 2021 Apr;28(1):e100223.
7. Baskaran V, Pearce F, Harwood RH, McKeever TM, Lim WS. Primary care consultations after hospitalisation for pneumonia: a large population-based cohort study. Br J Gen Pract. 2021 Mar 26;71(705):e250-e257.
8. Bhamra N, Osborne MS, Balai E, Jolly K, Barraclough J. Prevalence of Patients Who Return to Theatre Post-Adenoidectomy: A Review of Hospital Episode Statistics Data (2012-2019). Cureus. 2021 Mar 18;13(3):e13980.
9. Stephens S, Chatterjee A, Coles V, Crawford R. The costs of treating vaginal and vulval cancer in England (2009–2015). BMC Public Health. 2020 Dec;20(1):1-8.
10. De Oliveira H, Prodel M, Lamarsalle L, Inada-Kim M, Ajayi K, Wilkins J, Sekelj S, Beecroft S, Snow S, Slater R, Orlowski A. “Bow-tie” optimal pathway discovery analysis of sepsis hospital admissions using the Hospital Episode Statistics database in England. JAMIA open. 2020 Oct;3(3):439-48.